Maurizio Cecconi | |
---|---|
Born | [3] | December 27, 1977
Nationality | Italy, Britain |
Education | St George’s University of London (2006-2010), Harvard Medical School (2014-2015), [lower-alpha 2] Universidad Autonoma de Madrid (2001), [lower-alpha 3] University of Udine(1996-2002,2002-2006) [4] [2] |
Occupation(s) | Anesthesiologist, intensivist, academic |
Medical career | |
Profession | Professor and Chair of the Department of Anesthesia and Intensive Care Units (at Humanitas Research Hospital), Vice President of the joint Medicine-Bioengineering degree (at Humanitas University) |
Institutions | Humanitas Research Hospital in Milan, [5] European Society of Intensive Care Medicine (ESICM), St George's Hospital in London (former NHS consultant) |
Awards | The Honorary Citizenship of Gonars, The Gastein Health Forum European Health Leadership Award (2021) [lower-alpha 4] [3] [6] [7] |
Awards | Silver Griffin from the University of Udine (2018) |
Academic background | |
Thesis | ICS Research Gold Medal Abstract Presentations: Evaluation of Novel Methods of Cardiac Output Monitoring in Critically Ill Patients (2007) |
Academic work | |
Discipline | Intensive care medicine,anesthesiology |
Sub-discipline | Life support,Organ dysfunction,Respiratory failure,Multiple organ dysfunction syndrome |
Institutions | Humanitas University (Milan) |
Main interests | Haemodynamic monitoring,haemodynamic optimisation,physiology of the critically ill patient,perioperative care,the physiology of shock,acute respiratory failure,sepsis,effects of balanced crystalloids on renal failure and mortality of critically ill patients,venous return |
Maurizio Cecconi Cavaliere OMRI FRCA FFICM is a British-Italian anesthesiologist,intensivist,and academic. Cecconi's research focuses on improving the outcomes of high risk surgical patients,especially with better risk identification and perioperative haemodynamic optimisation,and improving the outcome of critically ill patients,especially suffering from cardiovascular shock,acute respiratory failure and sepsis. He has been Clinical Director of Adult Critical Care at St George's and the Clinical Lead for critical care at Epsom and St Helier's hospital from 2015 to 2016. [2] He was President of the European Society of Intensive Care Medicine (ESICM) from 2020 to 2022 throughout the COVID-19 Pandemic. [3] Cecconi has been the Head of the Department and Full Professor of Anaesthesia and Intensive Care at Humanitas Research Hospital and Humanitas University since 2018.
Cecconi attended the Scientific High School G. Marinelli in Udine. [3] [6] Cecconi graduated from the University of Udine in 2002. He won a grant from the Italian Society of Anaesthesia,Analgesia and Intensive Care (SIAARTI) and became a visiting fellow at St George's Hospital. At St George,Cecconi studied perioperative haemodynamic optimisation of the high risk surgical patient. He studied the evaluation of novel techniques for measuring cardiac output in critically ill patients,and in 2007 he got his Doctor of Medicine from the University of London. Cecconi got a scholarchip to study for a semester at the Autonomous University of Madrid in 2001. He completed his research studies with a research programme GCSRT at Harvard Medical School in 2015. [3] [8]
In 2008,Cecconi worked as a consultant for the NHS and became one of the youngest NHS consultants. [9]
In 2011,Cecconi became the Research Lead for the Adult Critical Care Directorate at St. George's University Hospitals in London, [10] and then became its Clinical Director in 2016. [2]
In 2016,Cecconi became the Clinical Director of Adult Critical Care at St George's Hospital in London and the Clinical Lead for critical care at Epsom and St Helier's hospital. [2]
In February 2018,and after 13 years in the UK,Cecconi returned to Italy to work for Humanitas. [3]
In a 2018 interview with Il Giorno,Cecconi said he returned to Italy to work at Humanitas due to its alignment with his vision of medicine combining clinical work and research. He is known for advocating a vision of anesthesia and intensive care that emphasizes the importance of research and patient outcomes. [10]
Cecconi said that his focus is on optimizing critically ill patients and high-risk surgical patients with tailored protocols. In another 2018 interview to a local publication,he said:
This means maintaining homeostasis in terms of pressure,oxygen transport,and cardiac output during and after the first few hours of surgery," he explained. "This practice has been shown to reduce the risk and postoperative complications and hospital stays. It improves the quality of hospitalizations and makes hospitals more efficient. Saint George's Hospital has always been a pioneer in this field,and I was able to do my research doctorate with them. [3]
The outbreak began on February 20 when a man in his 30s was admitted to Codogno Hospital,leading to 36 COVID-19 cases in less than 24 hours. Italy had reported 13,882 cases with 803 deaths at that time. ICU resources in Lombardy were quickly overwhelmed. Before the outbreak,there were 720 ICU beds (5% of total beds). Within days,they increased to 130 COVID-19 ICU beds,and by March 7,there were 482. ICU admissions represented 12% of positive cases,much higher than China's 5%,likely due to different admission criteria. The death rate increased with age,ranging from under 1% for those under 59 to 16.6% for those aged 80–89. Model forecasts projected a potential dramatic increase in cases,with ICU capacity exceeding soon. At the time,Cecconi advised countries without major outbreaks to focus on training staff to handle highly contagious patients and to prioritize evidence-based treatment and supportive care. He also discouraged untested approaches that could harm patients,emphasizing the importance of evidence-based care. [11] [12] [13] [14]
In March 2020,the Lombardy region in Italy faced a severe strain on its medical system due to the rapid outbreak of COVID-19. On 5 March,Cecconi sent a letter with Pesenti,Grasselli and Kesecioglu to describe the first 10 days of the COVID19 outbreak in Italy and to tell colleagues around the world to "get ready". [15] Cecconi spoke about the situation during a JAMA live stream interview on 13 March. [16] The live stream reached 500,000 viewers. On 28 March he organised an 8-hour COVID-19 online marathon which connected thousands of clinicians worldwide to be updated about the virus,how to control its spread and how to treat infected patients.
In June 2020,Cecconi warned that lockdown restrictions might return in the event of a second wave of COVID-19. In an interview with the Guardian,he emphasized the need to "learn how to live" with the virus until a vaccine became widely available and expressed optimism about European health authorities' efforts to monitor the virus. Cecconi criticized the British government for not implementing lockdown measures sooner,pointing to the herd immunity strategy as a "dangerous approach." [9]
In 2020,Cecconi was awarded the Knight of the Order of the Merit of the Italian Republic by president Sergio Mattarella for his service "to the community during the coronavirus emergency". [1] [17] During the same year,JAMA named Cecconi as one of the most influential doctors of the COVID-19 pandemic [18] alongside other notable figures like Li Wenliang and Anthony Fauci. Cecconi emphasized the importance of collaboration and sharing of information among medical professionals to better prepare for future crises. [19] [20] During the time of his presidency over the European Society of Intensive Care Medicine (ESICM),the organization won the Gastein Health Forum European Health Leadership Award in 2021. As of September 2023,he is the chair of Editorial and Publishing Committee at ESICM. [2]
In June 2021,Cecconi received an Honorary Citizenship of Gonars. [6]
In December 2022,Cecconi wrote an opinion piece for Corriere della Sera in which he highlighted that the previous few years revealed critical issues like antibiotic resistance and the need to rethink intensive care services. Antibiotic resistance,exacerbated by misuse,was a pre-existing problem,causing millions of deaths globally and during the pandemic,some people incorrectly used antibiotics for viral infections. Cecconi said that healthcare systems needed to integrate with the community for vaccination campaigns and public awareness initiatives to detect early symptoms,reducing the reliance on intensive care. He also emphasized the role of Hera,the Authority for Preparedness and Response to Health Emergencies,and EPIC-IG,an interest group on intensive medicine in the European Parliament. [21]
In June 2023,Cecconi co-wrote an opinion piece with Sirpa Pietikäinen for Lapin Kansa. [lower-alpha 5] They expressed their concerns regarding the recent studies showing over 70 percent of all antimicrobial drugs worldwide being given to animals that are raised for food consumption. [22] [23]
Delirium is a specific state of acute confusion attributable to the direct physiological consequence of a medical condition, effects of a psychoactive substance, or multiple causes, which usually develops over the course of hours to days. As a syndrome, delirium presents with disturbances in attention, awareness, and higher-order cognition. People with delirium may experience other neuropsychiatric disturbances including changes in psychomotor activity, disrupted sleep-wake cycle, emotional disturbances, disturbances of consciousness, or, altered state of consciousness, as well as perceptual disturbances, although these features are not required for diagnosis.
Intensive care medicine, usually called critical care medicine, is a medical specialty that deals with seriously or critically ill patients who have, are at risk of, or are recovering from conditions that may be life-threatening. It includes providing life support, invasive monitoring techniques, resuscitation, and end-of-life care. Doctors in this specialty are often called intensive care physicians, critical care physicians, or intensivists.
Acute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by rapid onset of widespread inflammation in the lungs. Symptoms include shortness of breath (dyspnea), rapid breathing (tachypnea), and bluish skin coloration (cyanosis). For those who survive, a decreased quality of life is common.
Ventilator-associated pneumonia (VAP) is a type of lung infection that occurs in people who are on mechanical ventilation breathing machines in hospitals. As such, VAP typically affects critically ill persons that are in an intensive care unit (ICU) and have been on a mechanical ventilator for at least 48 hours. VAP is a major source of increased illness and death. Persons with VAP have increased lengths of ICU hospitalization and have up to a 20–30% death rate. The diagnosis of VAP varies among hospitals and providers but usually requires a new infiltrate on chest x-ray plus two or more other factors. These factors include temperatures of >38 °C or <36 °C, a white blood cell count of >12 × 109/ml, purulent secretions from the airways in the lung, and/or reduction in gas exchange.
The sequential organ failure assessment score, previously known as the sepsis-related organ failure assessment score, is used to track a person's status during the stay in an intensive care unit (ICU) to determine the extent of a person's organ function or rate of failure. The score is based on six different scores, one each for the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems.
An intensive care unit (ICU), also known as an intensive therapy unit or intensive treatment unit (ITU) or critical care unit (CCU), is a special department of a hospital or health care facility that provides intensive care medicine.
The Surviving Sepsis Campaign (SSC) is a global initiative to bring together professional organizations in reducing mortality from sepsis. The purpose of the SSC is to create an international collaborative effort to improve the treatment of sepsis and reduce the high mortality rate associated with the condition. The Surviving Sepsis Campaign and the Institute for Healthcare Improvement have teamed up to achieve a 25 percent reduction in sepsis mortality by 2009. The guidelines were updated in 2016 and again in 2021.
Early goal-directed therapy was introduced by Emanuel P. Rivers in The New England Journal of Medicine in 2001 and is a technique used in critical care medicine involving intensive monitoring and aggressive management of perioperative hemodynamics in patients with a high risk of morbidity and mortality. In cardiac surgery, goal-directed therapy has proved effective when commenced after surgery. The combination of GDT and Point-of-Care Testing has demonstrated a marked decrease in mortality for patients undergoing congenital heart surgery. Furthermore, a reduction in morbidity and mortality has been associated with GDT techniques when used in conjunction with an electronic medical record.
A stress ulcer is a single or multiple mucosal defect usually caused by physiological stress which can become complicated by upper gastrointestinal bleeding. These ulcers can be caused by shock, sepsis, trauma or other conditions and are found in patients with chronic illnesses. These ulcers are a significant issue in patients in critical and intensive care.
The Horowitz index or Horovitz index is a ratio used to assess lung function in patients, particularly those on ventilators. Overall, it is useful for evaluating the extent of damage to the lungs. The simple abbreviation as oxygenation can lead to confusion with other conceptualizations of oxygenation index.
The Society of Intensive Care Medicine (SICM) is the representative body for Intensive Care Medicine (ICM) professionals in Singapore.
Derek Calder Angus is an American-based, British medical scientist, whose work focuses on clinical, epidemiologic and translational studies of sepsis, pneumonia, multisystem organ failure and the organization and delivery of critical care services.
Paul Ellis Marik is an American physician and former professor of medicine. Until his resignation in January 2022, he served as chair of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School in Norfolk, Virginia, and was also a critical care doctor at Sentara Norfolk General Hospital. His research interests include sepsis and tissue oxygenation. In August 2023 the American Board of Internal Medicine informed Marik his certification was to be revoked for spreading misinformation. The revocation followed in August 2024.
Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.
Proning or prone positioning is the placement of patients into a prone position so that they are lying on their front. This is used in the treatment of patients in intensive care with acute respiratory distress syndrome (ARDS). It has been especially tried and studied for patients on ventilators but, during the COVID-19 pandemic, it is being used for patients with oxygen masks and CPAP as an alternative to ventilation.
The treatment and management of COVID-19 combines both supportive care, which includes treatment to relieve symptoms, fluid therapy, oxygen support as needed, and a growing list of approved medications. Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the estimated millions of immunocompromised persons who are unlikely to respond robustly to vaccination, treatment remains important. Some people may experience persistent symptoms or disability after recovery from the infection, known as long COVID, but there is still limited information on the best management and rehabilitation for this condition.
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is an international research initiative based in Oxford, England. It is hosted at the Nuffield Department of Medicine within the University of Oxford and led by the Epidemic diseases Research Group Oxford (ERGO). ISARIC is funded by the Bill & Melinda Gates Foundation, Foreign, Commonwealth and Development Office, and Wellcome Trust.
Anthony Gordon is a British clinician scientist and the Chair of Anaesthesia & Critical Care at Imperial College London and works as an intensive care consultant at Imperial College Healthcare NHS Trust.
Jane Eddleston is a British medical doctor, professor and critical care consultant at Manchester Royal Infirmary. In 2022 she became the first woman doctor to win the Faculty of Intensive Care Medicine Gold Medal.
{{cite web}}
: CS1 maint: numeric names: authors list (link)